Clinical Research Directory
Browse clinical research sites, groups, and studies.
Kintsugi Voice Device Pivotal Study
Sponsor: Kintsugi Mindful Wellness, Inc.
Summary
A prospective, single arm, non-randomized, pivotal clinical validation study to evaluate the ability of the Kintsugi Voice Device (the Device) to aid clinical assessment for depression by comparing its output with a diagnosis made by a clinician using the Structured Clinical Interview for DSM-5 (SCID-5-RV) for up to 1000 English speaking adult patients ages 22 and older living in the United States. Recruitment will occur for 1 year and participation will be for up to 2 weeks
Official title: Kintsugi Voice Device SCID-5 Pivotal Study
Key Details
Gender
All
Age Range
22 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2025-03-27
Completion Date
2025-11
Last Updated
2025-04-30
Healthy Volunteers
Yes
Interventions
Kintsugi Voice Device
The Kintsugi Voice Device is intended to be used to screen for the presence of voice signals consistent with a current moderate to severe depressive episode in patients aged 22 and older. The device is intended to be used by care providers licensed to screen for depression and in settings where the screening for depression occurs. The device is neither to be used in lieu of a complete patient evaluation nor to supplant any of the clinician's standard assessments for the screening or diagnosis of depression. The Kintsugi Voice Device is comprised of a software API and machine learning model that utilizes recorded voice samples as inputs and outputs the detection of signals consistent with current moderate to severe depressive episode as outputs.
Locations (1)
Kintsugi (Decentralized, Virtual Study)
Berkeley, California, United States